Main interest in ovarian and endometrial cancer screening. Alex is part of the core team of the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), a randomised controlled trial involving 202,638 women from the UK assessing the mortality impact of screening. She has also been involved in the International Ovarian Cancer Association Consortium (OCAC) looking at genetic predisposition to ovarian cancer and has contributed to a number of publications in this field. Alex has an interest in the menopause transition and the therapies that women use to alleviate their menopausal symptoms. Other interests include biomarker discovery for ovarian as well as other cancers.